by Plus Therapeutics | Mar 13, 2024 | Uncategorized
AVAILABLE NOW: The new Plus Therapeutics corporate presentation, which reflects our current data, milestones, and pipeline, is on our website. View it directly here: https://bit.ly/3PiHClj Questions about anything or interested in learning more? Visit our website at...
by Plus Therapeutics | Mar 7, 2024 | Uncategorized
We are thrilled to announce our sponsorship with @glioblastomaresearch this upcoming season on their “Glioblastoma AKA GBM” podcast! 🧠 We appreciate their goal of raising awareness and funds for new global, cutting-edge research to find a cure for...
by Plus Therapeutics | Feb 29, 2024 | Uncategorized
Today on leap day, the rarest day of the year, we celebrate Rare Disease Day along with the NIH and other organizations. Plus Therapeutics is dedicated to developing innovative, targeted radiotherapeutics for adult & pediatric patients with rare &...
by Plus Therapeutics | Feb 28, 2024 | Uncategorized
We are excited to announce our national partnership with @HeadfortheCure! 🎉 Their goals of building awareness, raising funds, and igniting hope for the brain tumor community strongly align with our mission. Look out for more information regarding our upcoming...
by Plus Therapeutics | Feb 26, 2024 | Uncategorized
We love working with the @the_ABTA and are so excited about our upcoming collaborative projects with them. More to come‼️ ABTA Brain Tumor Resources: https://www.abta.org/about-brain-tumors/ ReSPECT-GBM Clinical Trial Patient Resource:...
by Plus Therapeutics | Feb 17, 2024 | Uncategorized
We will see you at the Nuclear Medicine Conference at the University of Mississippi Medical Center this weekend! Come grab some information on our ReSPECT-GBM and ReSPECT-LM clinical trials Home #NuclearMedicine #ClinicalTrials #Oncology...
Recent Comments